Processa Pharmaceuticals, Inc.

PCSANASDAQ Capital Market·USD·Closed

PCSANASDAQ·USD·Closed

$2.15

+5.39%

$2.15

+$0.11 (5.39%)

52W Range

4thpctl

Volume

1.67×avg

Mkt Cap

5.95MUSD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

4thpctl

Volume

1.67×avg

Market Cap

5.95MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-569.6%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio0.98×